Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
$0.60
$0.60
$0.00
▼
$0.80
$35.79M1.7515,632 shsN/A
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
$0.20
$0.20
$0.18
▼
$1.94
$9.52M1.573.75 million shsN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$0.16
-6.2%		$0.14
$0.12
▼
$0.53
$35.77M0.2756,465 shs521,786 shs
United-Guardian, Inc. stock logo
UG
United-Guardian
$7.15
-0.7%		$7.27
$5.58
▼
$8.77
$32.85M0.957,615 shs9,374 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
0.00%0.00%0.00%0.00%+1,712.46%
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
0.00%0.00%0.00%0.00%-18.08%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00%+10.10%+21.54%-25.61%-24.76%
United-Guardian, Inc. stock logo
UG
United-Guardian
0.00%0.00%+1.92%+3.17%-11.62%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
$0.60
$0.60
$0.00
▼
$0.80
$35.79M1.7515,632 shsN/A
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
$0.20
$0.20
$0.18
▼
$1.94
$9.52M1.573.75 million shsN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$0.16
-6.2%		$0.14
$0.12
▼
$0.53
$35.77M0.2756,465 shs521,786 shs
United-Guardian, Inc. stock logo
UG
United-Guardian
$7.15
-0.7%		$7.27
$5.58
▼
$8.77
$32.85M0.957,615 shs9,374 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
0.00%0.00%0.00%0.00%+1,712.46%
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
0.00%0.00%0.00%0.00%-18.08%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00%+10.10%+21.54%-25.61%-24.76%
United-Guardian, Inc. stock logo
UG
United-Guardian
0.00%0.00%+1.92%+3.17%-11.62%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
0.00
N/AN/AN/A
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
1.00
SellN/AN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00
N/AN/AN/A
United-Guardian, Inc. stock logo
UG
United-Guardian
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest EPIX, ADXS, PYRGF, and UG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/21/2026
United-Guardian, Inc. stock logo
UG
United-Guardian
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
7/8/2026
United-Guardian, Inc. stock logo
UG
United-Guardian
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
$3.24M11.05N/AN/A($2.06) per share-0.29
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
N/AN/AN/AN/A$2.81 per shareN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$9.14M3.91N/AN/A($0.01) per share-15.80
United-Guardian, Inc. stock logo
UG
United-Guardian
$11.21M2.93$0.48 per share14.84$2.53 per share2.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
-$48.07M-$5.02N/AN/AN/AN/AN/AN/AN/A
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
-$28.54M-$0.56N/AN/AN/AN/A-21.71%-21.22%N/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
-$21.12M-$0.04N/AN/AN/A-115.14%N/A-60.81%N/A
United-Guardian, Inc. stock logo
UG
United-Guardian
$2.11M$0.5413.24N/AN/A22.01%22.24%19.12%N/A

Latest EPIX, ADXS, PYRGF, and UG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q2 2026
United-Guardian, Inc. stock logo
UG
United-Guardian
N/A$0.16N/A$0.16N/A$3.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
N/AN/AN/AN/AN/A
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
$1.69839.96%N/AN/A N/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/AN/AN/AN/AN/A
United-Guardian, Inc. stock logo
UG
United-Guardian
$0.608.39%-5.11%111.11%1 Years

Latest EPIX, ADXS, PYRGF, and UG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/14/2026
United-Guardian, Inc. stock logo
UG
United-Guardian
$0.308.19%7/28/20267/28/20268/4/2026
1/1/2100
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
--$1.698/25/20258/19/20258/22/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
N/AN/AN/A
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
N/A
69.06
69.06
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/A
0.60
0.50
United-Guardian, Inc. stock logo
UG
United-Guardian
N/A
7.32
6.64

Institutional Ownership

CompanyInstitutional Ownership
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
7.18%
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
75.12%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.03%
United-Guardian, Inc. stock logo
UG
United-Guardian
23.16%

Insider Ownership

CompanyInsider Ownership
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
0.63%
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
15.50%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
47.68%
United-Guardian, Inc. stock logo
UG
United-Guardian
29.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Ayala Pharmaceuticals, Inc. stock logo
ADXS
Ayala Pharmaceuticals
2059.31 million42.36 millionNot Optionable
ESSA Pharma Inc. stock logo
EPIX
ESSA Pharma
5047.31 million39.98 millionOptionable
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
90226.36 million96.34 millionNo Data
United-Guardian, Inc. stock logo
UG
United-Guardian
204.59 million3.26 millionNot Optionable

Recent News About These Companies

United-Guardian (NASDAQ:UG) Shares Cross Below Fifty Day Moving Average - What's Next?
August 27 at 3:24 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30986142
UG Q2 Earnings Rise Y/Y on Strong Cosmetic Ingredient Sales
August 14, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2975099/ug-q2-earnings-rise-y-y-on-strong-cosmetic-ingredient-sales?cid=cs-stocknewsapi-ft-microcap_article|earnings-2975099
United-Guardian: Q2 Earnings Snapshot
August 7, 2026  |  wtop.comW
United-Guardian Reports Second Quarter Results
August 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341220/24183/en/united-guardian-reports-second-quarter-results.html
United-Guardian Insider Trading Activity | NASDAQ:UG | Benzinga
July 16, 2026  |  benzinga.comhttps://www.benzinga.com/quote/UG/insider-trades
United-Guardian Declares Cash Dividend
July 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/16/3328497/24183/en/united-guardian-declares-cash-dividend.html
UG Outperforms Industry in 6 Months: Buy, Sell or Hold the Stock?
July 8, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2950303/ug-outperforms-industry-in-6-months-buy-sell-or-hold-the-stock?cid=cs-stocknewsapi-ft-microcap_article|investment_ideas-2950303
Engages Danayi Capital Corp. To Provide Digital Marketing Services
June 12, 2026  |  thenewswire.comT
Upside Gold Corp. Announces Closing of $5 Million Brokered Private Placement
June 12, 2026  |  thenewswire.comT
Upside Gold Corp. Announces Closing of $5 Million Brokered Private Placement
June 12, 2026  |  thenewswire.comT
Upside Gold Announces Fully Permitted Drill Program at the Kena Gold-Copper Project
May 27, 2026  |  thenewswire.comT
United-Guardian Q1 Earnings Rise Y/Y on Strong Renacidin Demand
May 18, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2922673/united-guardian-q1-earnings-rise-y-y-on-strong-renacidin-demand?cid=cs-stocknewsapi-ft-microcap_article|earnings-2922673
United-Guardian, Inc. (UG) Shareholder/Analyst Call Transcript
May 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4904049-united-guardian-inc-ug-shareholder-analyst-call-transcript
Upside Gold Corp. Finalizes Acquisition of Strategic High-Grade Gold Claims Adjacent to the Kena Project
May 13, 2026  |  thenewswire.comT
United-Guardian Reports First Quarter Results
May 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/08/3291077/24183/en/united-guardian-reports-first-quarter-results.html
Upside Gold Corp. Signs LOI For Strategic Claims Adjacent To The Kena Property
April 27, 2026  |  thenewswire.comT
Upside Gold Corp. Announces Grant Of Stock Options
April 9, 2026  |  thenewswire.comT
United-Guardian 2025 Earnings Fall Y/Y Amid Weak Sales Trends
March 31, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2892248/united-guardian-2025-earnings-fall-y-y-amid-weak-sales-trends?cid=cs-stocknewsapi-ft-microcap_article|earnings-2892248
United-Guardian: Q4 Earnings Snapshot
March 27, 2026  |  khou.comK
United-Guardian Reports 2025 Financial Results
March 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/27/3263783/24183/en/united-guardian-reports-2025-financial-results.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Ayala Pharmaceuticals stock logo

Ayala Pharmaceuticals NASDAQ:ADXS

$0.60 0.00 (0.00%)
As of 08/28/2026

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

ESSA Pharma stock logo

ESSA Pharma NASDAQ:EPIX

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

PyroGenesis Canada stock logo

PyroGenesis Canada NASDAQ:PYRGF

$0.16 -0.01 (-6.18%)
As of 08/28/2026 03:21 PM Eastern

PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. The company offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. It provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montreal, Canada.

United-Guardian stock logo

United-Guardian NASDAQ:UG

$7.15 -0.05 (-0.69%)
As of 08/28/2026 04:00 PM Eastern

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas